| P50 | author | Juliana Lott Carvalho | Q56860463 |
| P2093 | author name string | Felipe Saldanha-Araujo | |
| | Martha de Oliveira Bravo | |
| P2860 | cites work | Natural killer cells acquire CD73 expression upon exposure to mesenchymal stem cells | Q87155796 |
| | Immune-related antigens, surface molecules and regulatory factors in human-derived mesenchymal stromal cells: the expression and impact of inflammatory priming | Q95411196 |
| | The A2b adenosine receptor mediates cAMP responses to adenosine receptor agonists in human intestinal epithelia | Q24311856 |
| | Identification and characterization of CD39/vascular ATP diphosphohydrolase | Q24336540 |
| | Adenosine receptors: therapeutic aspects for inflammatory and immune diseases | Q24651475 |
| | Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes | Q24673317 |
| | Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells | Q24681395 |
| | Development of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung Cancer | Q26798047 |
| | CD73 and CD39 ectonucleotidases in T cell differentiation: Beyond immunosuppression | Q26801436 |
| | CD73-generated adenosine: orchestrating the tumor-stroma interplay to promote cancer growth | Q26823709 |
| | Purinergic signaling: a common pathway for neural and mesenchymal stem cell maintenance and differentiation | Q26865695 |
| | The A3 adenosine receptor: history and perspectives | Q27021898 |
| | The PI3K-NF-kappaB signal transduction pathway is involved in mediating the anti-inflammatory effect of IB-MECA in adjuvant-induced arthritis | Q28195442 |
| | Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4 | Q28204758 |
| | The inhibitory cytokine IL-35 contributes to regulatory T-cell function | Q28258462 |
| | Ecto-enzyme and signaling functions of lymphocyte CD73 | Q28268472 |
| | Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts | Q28269878 |
| | Human mesenchymal stem cells modulate allogeneic immune cell responses | Q28288692 |
| | Expression of A2B adenosine receptors in human lymphocytes: their role in T cell activation | Q28294720 |
| | Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion | Q28507222 |
| | Cloning of two adenosine receptor subtypes from mouse bone marrow-derived mast cells | Q28508311 |
| | Adenosine receptors as drug targets--what are the challenges? | Q29346491 |
| | Multilineage cells from human adipose tissue: implications for cell-based therapies | Q29547688 |
| | Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression | Q29615344 |
| | Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells | Q29618766 |
| | Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli | Q29618769 |
| | CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production | Q29619536 |
| | Mesenchymal stem cells | Q29619804 |
| | Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses | Q29619908 |
| | Human mesenchymal stem cells modulate B-cell functions | Q29620705 |
| | Human bronchial fibroblasts exhibit a mesenchymal stem cell phenotype and multilineage differentiating potentialities | Q30160229 |
| | Cell therapy for cardiac repair--lessons from clinical trials. | Q30359782 |
| | Regulatory T cells in AKI. | Q30409790 |
| | Autocrine adenosine signaling promotes regulatory T cell-mediated renal protection | Q30417431 |
| | Links between insulin resistance, adenosine A2B receptors, and inflammatory markers in mice and humans | Q30428503 |
| | Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system | Q30472844 |
| | Adenosine: an old drug newly discovered | Q33555006 |
| | CD39-mediated effect of human bone marrow-derived mesenchymal stem cells on the human Th17 cell function | Q33692614 |
| | Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells | Q33748026 |
| | Characterization of protective human CD4CD25 FOXP3 regulatory T cells generated with IL-2, TGF-β and retinoic acid | Q33778359 |
| | Treating inborn errors of liver metabolism with stem cells: current clinical development | Q33870631 |
| | Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells | Q33873201 |
| | Extracellular adenosine-mediated modulation of regulatory T cells | Q33878542 |
| | Adenosine signaling during acute and chronic disease states | Q34035228 |
| | Adenosine and prostaglandin E2 cooperate in the suppression of immune responses mediated by adaptive regulatory T cells | Q34107172 |
| | How does methotrexate suppress inflammation? | Q34147592 |
| | Multipotent mesenchymal stromal cells express FoxP3: a marker for the immunosuppressive capacity? | Q34149057 |
| | Adora2b adenosine receptor engagement enhances regulatory T cell abundance during endotoxin-induced pulmonary inflammation | Q34184568 |
| | Enhanced suppressor function of TIM-3+ FoxP3+ regulatory T cells | Q34195216 |
| | Regulatory T cells enhance mesenchymal stem cell survival and proliferation following autologous cotransplantation in ischemic myocardium | Q34279141 |
| | Adenosine: an endogenous regulator of innate immunity | Q34286701 |
| | Indoleamine 2,3 dioxygenase and metabolic control of immune responses | Q34308495 |
| | Regulatory T cell-derived exosomes: possible therapeutic and diagnostic tools in transplantation | Q34454926 |
| | Immunomodulatory effects of caffeine: friend or foe? | Q34502438 |
| | Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta | Q34517421 |
| | Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. | Q34529123 |
| | Human T regulatory cells can use the perforin pathway to cause autologous target cell death | Q34551876 |
| | Isolation and characterization of human antigen-specific TCR alpha beta+ CD4(-)CD8- double-negative regulatory T cells | Q34552979 |
| | T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5'-adenosine monophosphate to adenosine | Q34578972 |
| | Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. | Q34621389 |
| | Graft-versus-host disease is enhanced by selective CD73 blockade in mice | Q34631798 |
| | Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells. | Q34751391 |
| | Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade | Q34756092 |
| | A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice | Q34826208 |
| | A novel mechanism of B cell-mediated immune suppression through CD73 expression and adenosine production | Q35064373 |
| | IL-10-producing T cells suppress immune responses in anergic tuberculosis patients | Q35159232 |
| | CD39 deficiency in murine liver allografts promotes inflammatory injury and immune-mediated rejection | Q35202450 |
| | The role of the adenosinergic pathway in immunosuppression mediated by human regulatory T cells (Treg). | Q37956691 |
| | New insights regarding the regulation of chemotaxis by nucleotides, adenosine, and their receptors | Q38005034 |
| | Mesenchymal stromal cells and regulatory T cells: the Yin and Yang of peripheral tolerance? | Q38059338 |
| | Cellular and molecular interactions of mesenchymal stem cells in innate immunity | Q38059340 |
| | Application of MultiStem(®) Allogeneic Cells for Immunomodulatory Therapy: Clinical Progress and Pre-Clinical Challenges in Prophylaxis for Graft Versus Host Disease | Q38064454 |
| | Paracrine mechanisms of proliferative, anti-apoptotic and anti-inflammatory effects of mesenchymal stromal cells in models of acute organ injury | Q38151419 |
| | Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. | Q38305613 |
| | Extracellular adenosine generation in the regulation of pro-inflammatory responses and pathogen colonization | Q38464138 |
| | Mesenchymal Stem Cell Therapy for Autoimmune Disease: Risks and Rewards | Q38525790 |
| | Human CD4+ CD39+ regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells | Q39002543 |
| | Combination of rapamycin and IL-2 increases de novo induction of human CD4(+)CD25(+)FOXP3(+) T cells | Q39299547 |
| | Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production. | Q39523865 |
| | Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype. | Q39698715 |
| | Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-gamma | Q40274827 |
| | Interactions between human mesenchymal stem cells and natural killer cells | Q40385365 |
| | Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells | Q40395279 |
| | Induced miR-99a expression represses Mtor cooperatively with miR-150 to promote regulatory T-cell differentiation | Q40506554 |
| | High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors | Q40610397 |
| | Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo | Q40662801 |
| | Neuroprotection by adenosine in the brain: From A(1) receptor activation to A (2A) receptor blockade | Q40722338 |
| | CD39 and control of cellular immune responses | Q40730152 |
| | Fc gamma receptor-mediated functions in neutrophils are modulated by adenosine receptor occupancy. A1 receptors are stimulatory and A2 receptors are inhibitory | Q41201229 |
| | Regulatory T cell-derived adenosine induces dendritic cell migration through the Epac-Rap1 pathway. | Q41205971 |
| | Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected]. | Q41907086 |
| | Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood | Q41973912 |
| | A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes | Q41983445 |
| | Expression of CD39 by human peripheral blood CD4+ CD25+ T cells denotes a regulatory memory phenotype. | Q41985015 |
| | Separation of human CD4+CD39+ T cells by magnetic beads reveals two phenotypically and functionally different subsets | Q42066000 |
| | Mechanisms of T-cell immunosuppression by mesenchymal stromal cells: what do we know so far? | Q42103653 |
| | Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses | Q42575579 |
| | The human carotid body: expression of oxygen sensing and signaling genes of relevance for anesthesia | Q42845569 |
| | Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure | Q42868532 |
| | Adenosine Receptor A1 Regulates Polymorphonuclear Cell Trafficking and Microvascular Permeability in Lipopolysaccharide-Induced Lung Injury | Q42930077 |
| | Immunomodulatory properties of pentoxifylline are mediated via adenosine-dependent pathways | Q43227039 |
| | De novo generation and enhanced suppression of human CD4+CD25+ regulatory T cells by retinoic acid | Q43283588 |
| | CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation | Q43406136 |
| | Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms | Q43508044 |
| | Adenosine inhibits neutrophil vascular endothelial growth factor release and transendothelial migration via A2B receptor activation | Q43575878 |
| | Expression and function of adenosine receptors in human dendritic cells | Q43726407 |
| | Cardiac myocyte adenosine A2a receptor activation fails to alter cAMP or contractility: role of receptor localization | Q43880527 |
| | Differential expression of adenosine receptors in human endothelial cells: role of A2B receptors in angiogenic factor regulation | Q43928343 |
| | Combined immunodeficiency disease associated with adenosine deaminase deficiency. Report on a workshop held in Albany, New York, October 1, 1973 | Q44456413 |
| | Activation of adenosine A1 receptor attenuates cardiac hypertrophy and prevents heart failure in murine left ventricular pressure-overload model | Q44582352 |
| | A1 adenosine receptor activation inhibits inflammation, necrosis, and apoptosis after renal ischemia-reperfusion injury in mice | Q44705269 |
| | Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation | Q44786842 |
| | Infarct-sparing effect of A2A-adenosine receptor activation is due primarily to its action on lymphocytes | Q44910151 |
| | Evidence for the involvement of nitric oxide in A2B receptor-mediated vasorelaxation of mouse aorta | Q44922677 |
| | Antiinflammatory effect of A3 adenosine receptor agonists in murine autoimmune arthritis models. | Q45293508 |
| | Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells. | Q45834735 |
| | Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients | Q45864185 |
| | The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes. | Q46010474 |
| | MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. | Q46034364 |
| | Bone marrow-derived mesenchymal stromal cells harness purinergenic signaling to tolerize human Th1 cells in vivo | Q35224328 |
| | The role of the combination of IL-2 and TGF-β or IL-10 in the generation and function of CD4+ CD25+ and CD8+regulatory T cell subsets | Q35547512 |
| | Jagged-1 is required for the expansion of CD4+ CD25+ FoxP3+ regulatory T cells and tolerogenic dendritic cells by murine mesenchymal stromal cells | Q35552588 |
| | Pharmacological and therapeutic effects of A3 adenosine receptor agonists | Q35788500 |
| | The development and immunosuppressive functions of CD4(+) CD25(+) FoxP3(+) regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway. | Q36075960 |
| | Expression of IL-37 contributes to the immunosuppressive property of human CD4+CD25+ regulatory T cells | Q36100192 |
| | MicroRNA-15b/16 Enhances the Induction of Regulatory T Cells by Regulating the Expression of Rictor and mTOR | Q36351026 |
| | CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness | Q36370807 |
| | The A2b adenosine receptor protects against vascular injury | Q36393058 |
| | Distinct roles for the A2B adenosine receptor in acute and chronic stages of bleomycin-induced lung injury. | Q36713583 |
| | Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go? | Q36821572 |
| | CD73+ regulatory T cells contribute to adenosine-mediated resolution of acute lung injury. | Q36860320 |
| | Concise review: the clinical application of mesenchymal stem cells for musculoskeletal regeneration: current status and perspectives | Q36862085 |
| | Priming mesenchymal stem cells boosts stem cell therapy to treat myocardial infarction | Q36881332 |
| | Myeloid-derived suppressor cells | Q36916250 |
| | Adenosine production by human B cells and B cell-mediated suppression of activated T cells | Q36983750 |
| | Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells | Q36998218 |
| | The rise of cell therapy trials for stroke: review of published and registered studies | Q37025630 |
| | Concise review: mesenchymal stem cells for diabetes | Q37056264 |
| | Differential effects of rapamycin and retinoic acid on expansion, stability and suppressive qualities of human CD4(+)CD25(+)FOXP3(+) T regulatory cell subpopulations | Q37060678 |
| | Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review). | Q37091784 |
| | Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkappaB. | Q37208648 |
| | Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other | Q37233905 |
| | Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expression | Q37245083 |
| | Mesenchymal stem cells promote the sustained expression of CD69 on activated T lymphocytes: roles of canonical and non-canonical NF-κB signalling | Q37295170 |
| | Extracellular adenosine regulates naive T cell development and peripheral maintenance | Q37322177 |
| | Diminished adenosine A1 receptor expression in pancreatic α-cells may contribute to the pathology of type 1 diabetes | Q37333575 |
| | A(2B) adenosine receptors in immunity and inflammation. | Q37373680 |
| | Regulatory T cells: how do they suppress immune responses? | Q37593768 |
| | tTregs, pTregs, and iTregs: similarities and differences | Q37695519 |
| | IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells | Q46040716 |
| | A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood | Q46284741 |
| | Modulation of murine dendritic cell function by adenine nucleotides and adenosine: involvement of the A(2B) receptor | Q46605600 |
| | Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. | Q46670167 |
| | Endogenous A1 adenosine receptors protect against hepatic ischemia reperfusion injury in mice | Q46715465 |
| | Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation | Q46760280 |
| | Adenosine, through the A1 receptor, inhibits vesicular MHC class I cross-presentation by resting DC. | Q46820722 |
| | Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells | Q47372947 |
| | Involvement of adenosine A2A receptor in sleep promotion | Q47755458 |
| | Regulation of murine inflammatory bowel disease by CD25+ and CD25- CD4+ glucocorticoid-induced TNF receptor family-related gene+ regulatory T cells | Q47777710 |
| | Adenosinergic Immunosuppression by Human Mesenchymal Stromal Cells Requires Co-Operation with T cells. | Q50273159 |
| | Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. | Q50640546 |
| | Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages. | Q50956366 |
| | CD39+ regulatory T cells attenuate allergic airway inflammation. | Q51050332 |
| | CD73 Pathway Contributes to the Immunosuppressive Ability of Mesenchymal Stem Cells in Intraocular Autoimmune Responses. | Q53250000 |
| | IL-10 Potentiates Differentiation of Human Induced Regulatory T Cells via STAT3 and Foxo1. | Q53347772 |
| | Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction. | Q53547964 |
| | Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. | Q54011232 |
| | Caspase inhibition via A3 adenosine receptors: a new cardioprotective mechanism against myocardial infarction. | Q54397580 |
| | Human CD8+CXCR3+ T cells have the same function as murine CD8+CD122+ Treg. | Q54473058 |
| | TGF-beta1 production by CD4+ CD25+ regulatory T cells is not essential for suppression of intestinal inflammation. | Q54641474 |
| | Anti-inflammatory and immunosuppressive effects of the A2A adenosine receptor. | Q55230640 |
| | Mesenchymal stromal cells up-regulate CD39 and increase adenosine production to suppress activated T-lymphocytes | Q56787014 |
| | Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype | Q56902900 |
| | Isolation of multipotent adult stem cells from the dermis of mammalian skin | Q57042245 |
| | Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors | Q57731080 |
| | Phenotypic and functional characterization of human CD25+ B cells | Q59526654 |
| | Human mesenchymal stem cells inhibit antibody production induced in vitro by allostimulation | Q60313622 |
| | Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells | Q61645531 |
| | Regulation of endothelial CD73 by adenosine: paracrine pathway for enhanced endothelial barrier function | Q73112984 |
| | The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine | Q73470605 |
| | Exogenous and endogenous adenosine inhibits fetal calf serum-induced growth of rat cardiac fibroblasts: role of A2B receptors | Q73841698 |
| | Multipotent mesenchymal stem cells from adult human synovial membrane | Q74384605 |
| | A2A-adenosine receptor reserve for coronary vasodilation | Q77142330 |
| | Adenosine A(2A) and A(2B) receptors mediated nitric oxide production in coronary artery endothelial cells | Q77354771 |
| | Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord | Q78799982 |
| | Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex | Q78833880 |
| | Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells | Q80057941 |
| | Inhibition of cytokine production and cytotoxic activity of human antimelanoma specific CD8+ and CD4+ T lymphocytes by adenosine-protein kinase A type I signaling | Q80491718 |
| | In search of the in vivo identity of mesenchymal stem cells | Q81485769 |
| | T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression | Q81704121 |
| | Inhibition of T-cell proliferation by murine multipotent mesenchymal stromal cells is mediated by CD39 expression and adenosine generation | Q82986187 |
| | High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation | Q84014638 |
| | CD39 expression in mesenchymal stromal cells | Q84576422 |
| | CD56brightCD16- NK Cells Produce Adenosine through a CD38-Mediated Pathway and Act as Regulatory Cells Inhibiting Autologous CD4+ T Cell Proliferation | Q85410539 |
| | Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model | Q86245224 |
| | IDO-independent suppression of T cell effector function by IFN-γ-licensed human mesenchymal stromal cells | Q87057765 |
| P433 | issue | 4 | |
| P921 | main subject | immunosuppression | Q1455316 |
| | mesenchymal stem cell | Q1922379 |
| P304 | page(s) | 595-609 | |
| P577 | publication date | 2016-08-25 | |
| P1433 | published in | Purinergic Signalling | Q15716545 |
| P1476 | title | Adenosine production: a common path for mesenchymal stem-cell and regulatory T-cell-mediated immunosuppression | |
| P478 | volume | 12 | |